| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |